SMAD7 and lung cancer: Our findings identified the oncogenic role of PRMT5 in human lung cancer and elucidated a novel mechanism underlying the modulation of the Smad7‐gp130‐STAT3 axis by PRMT5 in those cancer types with aberrantly hyperactivation of STAT3.